Cargando…

The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer

PURPOSE: Study reported that C-reactive protein (CRP) would peak at 48 h after the initiation of an acute inflammatory response. We proposed that the ratio of CRP level on postoperative day 3 to day 2 (POD3/2 CRP) can be used to early predict major postoperative complications (PCs) for patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Bin, Liao, Qianchao, Zheng, Jiabin, Hu, Weixian, Yao, Xueqing, Li, Yong, Wang, Junjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283359/
https://www.ncbi.nlm.nih.gov/pubmed/35199220
http://dx.doi.org/10.1007/s00423-022-02469-w
_version_ 1784747294552227840
author Luo, Bin
Liao, Qianchao
Zheng, Jiabin
Hu, Weixian
Yao, Xueqing
Li, Yong
Wang, Junjiang
author_facet Luo, Bin
Liao, Qianchao
Zheng, Jiabin
Hu, Weixian
Yao, Xueqing
Li, Yong
Wang, Junjiang
author_sort Luo, Bin
collection PubMed
description PURPOSE: Study reported that C-reactive protein (CRP) would peak at 48 h after the initiation of an acute inflammatory response. We proposed that the ratio of CRP level on postoperative day 3 to day 2 (POD3/2 CRP) can be used to early predict major postoperative complications (PCs) for patients who underwent laparoscopic radical gastrectomy. METHODS: Patients were randomized into training cohort and validation cohort at a ratio of 7:3. PCs greater than grade II or more, according to Clavien-Dindo classification, were defined as major PCs. Three predictive models for major PCs based on CRP level were constructed, including POD3/2 CRP, the CRP level on POD3 (POD3 CRP), and the ratio of CRP level on POD3 to POD1 (POD3/1 CRP). The performances of three prediction models were assessed by AUC. Univariate and multivariate logistic regression analyses were performed to identify risk factors of major PCs. RESULTS: 344 patients were included. Major PCs were observed in 57 patients (16.6%). In the training cohort, POD3/2 CRP provided the best diagnostic accuracy with an AUC of 0.929 at an optimal cut-off value of 1.08, and the sensitivity and specificity were 0.902 and 0.880, respectively. In the validation cohort, the corresponding AUC was 0.917. BMI ≥ 25 kg/m(2) and POD3/2 CRP > 1 were identified as risk factors for major PCs. CONCLUSION: POD3/2 CRP is a reliable marker to predict major PCs after laparoscopic radical gastrectomy. If CRP is higher on POD3 than on POD2, major PCs are highly likely. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00423-022-02469-w.
format Online
Article
Text
id pubmed-9283359
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-92833592022-07-16 The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer Luo, Bin Liao, Qianchao Zheng, Jiabin Hu, Weixian Yao, Xueqing Li, Yong Wang, Junjiang Langenbecks Arch Surg Original Article PURPOSE: Study reported that C-reactive protein (CRP) would peak at 48 h after the initiation of an acute inflammatory response. We proposed that the ratio of CRP level on postoperative day 3 to day 2 (POD3/2 CRP) can be used to early predict major postoperative complications (PCs) for patients who underwent laparoscopic radical gastrectomy. METHODS: Patients were randomized into training cohort and validation cohort at a ratio of 7:3. PCs greater than grade II or more, according to Clavien-Dindo classification, were defined as major PCs. Three predictive models for major PCs based on CRP level were constructed, including POD3/2 CRP, the CRP level on POD3 (POD3 CRP), and the ratio of CRP level on POD3 to POD1 (POD3/1 CRP). The performances of three prediction models were assessed by AUC. Univariate and multivariate logistic regression analyses were performed to identify risk factors of major PCs. RESULTS: 344 patients were included. Major PCs were observed in 57 patients (16.6%). In the training cohort, POD3/2 CRP provided the best diagnostic accuracy with an AUC of 0.929 at an optimal cut-off value of 1.08, and the sensitivity and specificity were 0.902 and 0.880, respectively. In the validation cohort, the corresponding AUC was 0.917. BMI ≥ 25 kg/m(2) and POD3/2 CRP > 1 were identified as risk factors for major PCs. CONCLUSION: POD3/2 CRP is a reliable marker to predict major PCs after laparoscopic radical gastrectomy. If CRP is higher on POD3 than on POD2, major PCs are highly likely. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00423-022-02469-w. Springer Berlin Heidelberg 2022-02-23 2022 /pmc/articles/PMC9283359/ /pubmed/35199220 http://dx.doi.org/10.1007/s00423-022-02469-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Luo, Bin
Liao, Qianchao
Zheng, Jiabin
Hu, Weixian
Yao, Xueqing
Li, Yong
Wang, Junjiang
The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer
title The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer
title_full The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer
title_fullStr The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer
title_full_unstemmed The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer
title_short The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer
title_sort ratio of serum c-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283359/
https://www.ncbi.nlm.nih.gov/pubmed/35199220
http://dx.doi.org/10.1007/s00423-022-02469-w
work_keys_str_mv AT luobin theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT liaoqianchao theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT zhengjiabin theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT huweixian theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT yaoxueqing theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT liyong theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT wangjunjiang theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT luobin ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT liaoqianchao ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT zhengjiabin ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT huweixian ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT yaoxueqing ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT liyong ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer
AT wangjunjiang ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer